WIPO logo
Celular | Deutsch | English | Español | Français | 日本語 | 한국어 | Русский | 中文 | العربية |
PATENTSCOPE

Pesquisa nas coleções internacionais e nacionais de patentes
World Intellectual Property Organization
Pesquisa
 
Navegação
 
Traduzir
 
Opções
 
Notícias
 
Conectar-se
 
Ajuda
 
Tradução automática
1. (WO2006034789) PROLINE DERIVATIVES
Dados bibliográficos mais recentes no arquivo da Secretaria Internacional   

№ de pub.:    WO/2006/034789    № do pedido internacional:    PCT/EP2005/010025
Data de publicação: 06.04.2006 Data de depósito internacional: 16.09.2005
CIP:
C07D 413/14 (2006.01), C07D 413/12 (2006.01), C07D 417/14 (2006.01), A61K 31/4025 (2006.01), A61P 7/02 (2006.01), A61P 9/10 (2006.01), A61P 35/00 (2006.01)
Requerentes: MERCK PATENT GMBH [DE/DE]; Frankfurter Strasse 250, 64293 Darmstadt (DE) (For All Designated States Except US).
MEDERSKI, Werner [DE/DE]; (DE) (For US Only).
TSAKLAKIDIS, Christos [GR/DE]; (DE) (For US Only).
DORSCH, Dieter [DE/DE]; (DE) (For US Only).
CEZANNE, Bertram [DE/DE]; (DE) (For US Only).
GLEITZ, Johannes [DE/DE]; (DE) (For US Only)
Inventores: MEDERSKI, Werner; (DE).
TSAKLAKIDIS, Christos; (DE).
DORSCH, Dieter; (DE).
CEZANNE, Bertram; (DE).
GLEITZ, Johannes; (DE)
Representante
comum:
MERCK PATENT GMBH; Frankfurter Strasse 250, 64293 Darmstadt (DE)
Dados da prioridade:
10 2004 047 255.6 29.09.2004 DE
Título (DE) PROLINDERIVATE
(EN) PROLINE DERIVATIVES
(FR) DERIVES DE PROLINE
Resumo: front page image
(DE)Neue Verbindungen der Formel (I) worin X, Y, R1, R2, R3, R4 und n die in Patentanspruch 1 angegebene Bedeutung haben, sind Inhibitoren des Koagulationsfaktors Xa und können zur Prophylaxe und/oder Therapie von thromboembolischen Erkrankungen und zur Behandlung von Tumoren eingesetzt werden.
(EN)The invention relates to novel compounds of formula (I), wherein X, Y, R1, R2, R3, R4 and n have the meaning cited in claim 1, are inhibitors of the coagulation factor Xa and can be used for the prophylaxis and/or therapy of thromboembolic diseases and for the treatment of tumours.
(FR)La présente invention concerne de nouveaux composés de formule (I) dans laquelle X, Y, R1, R2, R3, R4 et n ont les significations énoncées dans la revendication 1. Ces composés sont des inhibiteurs du facteur de coagulation Xa et peuvent être utilisés afin de prévenir et/ou traiter des maladies thromboemboliques et de traiter des tumeurs.
Estados designados: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Língua de publicação: German (DE)
Língua de depósito: German (DE)